Efecte - Positive Business Momentum
2022-07-21 07:00:00
Redeye retains its positive view towards Efecte following an H1 report in line with our expectations, showing solid SaaS growth, an impressive churn rate, and an expanding partner network. We leave our Base Case unchanged.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/